In the clinic, a 1:1 mixture of separate CD4+ CAR-T cells and CD8+ CAR-T cells was found to be highly efficacious in adult B-ALL patients [31]. This evidence concerns the gene CD8A and precursor B-cell acute lymphoblastic leukemia.